Module Database Search

MODULE DESCRIPTOR
Module Title
Therapeutics
Reference	PHM032	Version	6
Created	August 2021	SCQF Level	SCQF 11
Approved	May 2011	SCQF Points	30
Amended	August 2021	ECTS Points	15

Aims of Module
To develop professional competence in therapeutic areas with emphasis on rational prescribing.

Learning Outcomes for Module
On completion of this module, students are expected to be able to:
1	Systematically apply knowledge and understanding of pathophysiology, clinical pharmacology and evidence based therapeutics for the specified disorders in a professional manner.
2	Critically evaluate a variety of types of numerical data, including biochemical, haematological, and pharmacokinetic parameters, to aid drug selection and monitoring for individual patients.
3	Systematically utilize evidence to critically evaluate patient data to solve therapeutic problems and synthesize a therapeutic plan that includes the selection, monitoring and counselling of drug therapy for individual patients.
4	Critically review current practice and reflect on individual performance in relation to drug therapeutics.

Indicative Module Content
DISEASE characteristics (refer to Additional Notes): epidemiology, aetiology, pathophysiology, clinical manifestations, signs/symptoms, abnormal results. Use of patient data including physical examination, physiological, biochemical and haematological parameters, to select, optimise and monitor drug therapy for conditions. DRUGS for the diseases: clinical pharmacology, pharmacokinetics. THERAPEUTIC PLANNING: evidence based approach to drug selection, monitoring: effectiveness and toxicity, counselling. Factors influencing prescribing and selection of therapy including patients' characteristics and drug factors, aspects of pharmacokinetics and pharmacodynamics. Management options including non-drug treatment.

Indicative Module Content

DISEASE characteristics (refer to Additional Notes): epidemiology, aetiology, pathophysiology, clinical manifestations, signs/symptoms, abnormal results. Use of patient data including physical examination, physiological, biochemical and haematological parameters, to select, optimise and monitor drug therapy for conditions. DRUGS for the diseases: clinical pharmacology, pharmacokinetics. THERAPEUTIC PLANNING: evidence based approach to drug selection, monitoring: effectiveness and toxicity, counselling. Factors influencing prescribing and selection of therapy including patients' characteristics and drug factors, aspects of pharmacokinetics and pharmacodynamics. Management options including non-drug treatment.

Module Delivery
Online distance learning supported by problem based study materials including directed reading and contact / structured discussion with peers and academic e-tutor staff.

Indicative Student Workload	Full Time	Part Time
Contact Hours	N/A	N/A
Non-Contact Hours	N/A	300
Placement/Work-Based Learning Experience [Notional] Hours	N/A	N/A
TOTAL	N/A	300
Actual Placement hours for professional, statutory or regulatory body

ASSESSMENT PLAN
If a major/minor model is used and box is ticked, % weightings below are indicative only.
Component 1
Type:	Coursework	Weighting:	100%	Outcomes Assessed:	1, 2, 3
Description:	Care plan with critical comment.
Component 2
Type:	Coursework	Weighting:	0%	Outcomes Assessed:	4
Description:	Reflective worksheets. Assessed on a PASS/FAIL basis.

MODULE PERFORMANCE DESCRIPTOR
Explanatory Text
To pass this module, the student must achieve a module Grade of Grade D or better.
Module Grade	Minimum Requirements to achieve Module Grade:
A	When C1 = A and C2 is passed.
B	When C1 = B and C2 is passed.
C	When C1 = C and C2 is passed.
D	When C1 = D and C2 is passed.
E	When C1 = E and C2 is passed.
F	When C1 = F AND/OR C2 is failed.
NS	Non-submission of work by published deadline or non-attendance for examination

Module Requirements
Prerequisites for Module	An undergraduate degree in a pharmacy, from a UK university or overseas equivalent, at a minimum of honours level and one years post-registration experience OR an integrated masters degree in pharmacy (MPharm) and professional registration OR in consultation with the Course Leader.
Corequisites for module	None.
Precluded Modules	None.

ADDITIONAL NOTES
This module is studied as three blocks, two blocks of core topics and one block of elective topics. Core topics: Cardiovascular - including hypertension, chronic cardiac failure, ischaemic heart disease, hyperlipidaemia. Endocrine - including diabetes mellitus, thyroid disorders. Respiratory - including asthma, chronic obstructive pulmonary disease. Musculoskeletal - including osteoarthritis, rheumatoid arthritis, pain. Infections - including, antimicrobial resistance, respiratory tract infections. Elective Topics: Oncology, Haematology, Psychiatry, Neurological conditions, Gastrointestinal diseases.

ADDITIONAL NOTES

This module is studied as three blocks, two blocks of core topics and one block of elective topics. Core topics: Cardiovascular - including hypertension, chronic cardiac failure, ischaemic heart disease, hyperlipidaemia. Endocrine - including diabetes mellitus, thyroid disorders. Respiratory - including asthma, chronic obstructive pulmonary disease. Musculoskeletal - including osteoarthritis, rheumatoid arthritis, pain. Infections - including, antimicrobial resistance, respiratory tract infections. Elective Topics: Oncology, Haematology, Psychiatry, Neurological conditions, Gastrointestinal diseases.

INDICATIVE BIBLIOGRAPHY
1	RALSTON, S. et al., current edition. Davidson's Principles and Practice of Medicine. London: Churchill Livingston.
2	BRITISH MEDICAL ASSOCIATION AND ROYAL PHARMACEUTICAL SOCIETY OF GREAT BRITAIN., current edition. British National Formulary. London: BMJ Publishing Group.

Robert Gordon University, Aberdeen

Module Database Search